February 11, 2021
A California biotech company and its CEO have agreed to settle a U.S. Securities and Exchange Commission suit alleging that they lied to investors about the development of a blood test for the coronavirus.
September 25, 2020
The U.S. Securities and Exchange Commission filed suit in California federal court Friday against a top executive of biotechnology company Arrayit Corp. who it says conned investors into believing the company had developed a COVID-19 test and misled them about the status of financial reports.